Invasive group B streptococcal infections in Sweden: Incidence, predisposing factors and prognosis

International Journal of Infectious Diseases

Volumn 7, Issue 2, 2003, Pages 113-119

  Dahl, Mats S ^a,b   Tessin, Ingemar ^a   Trollfors, Birger ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Dept Anaesthesia and Intensive Care   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BACTERIUM ISOLATE; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; PATHOGENESIS; PREMATURITY; PROGNOSIS; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SWEDEN;

EID: 0037662906     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90006-3     Document Type: Article

References (36)

1. Schuchat A, Wenger JD. Epidemiology of group B Streptococcal disease. Epidemiol Rev 1994; 16:374-402.
2. McCracken GH Jr. Group B streptococci; the new challenge in neonatal infections. J Pediatr 1973; 82:703-706.
3. Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, Warshaw JB, Baltimore RS. A half century of neonatal sepsis at Yale, 1929 to 1978. Am J Dis Child 1981; 135:140-144.
4. Vesikari T, Janas M, Gronroos P, et al. Neonatal septicaemia. Arch Dis Child 1985; 60:542-546.
5. Speer CP, Hauptmann D, Stubbe P, Gahr M. Neonatal septicaemia and meningitis in Göttingen, West Germany. Pediatr Infect Dis 1985; 4:36-41.
6. Tessin I, Trollfors B, Thiringer K. Incidence and etiology of neonatal septicemia and meningitis in western Sweden 1975-1986. Acta Paediatr Scand 1990; 79:1023-1030.
7. Hussain SM, Luedtke GS, Baker CJ, Schlievert PM, Leggiadro RJ. Invasive group B streptococcal disease beyond early infancy. Pediatr Infect Dis J 1995; 14:278-281.
8. Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328:1807-1811.
9. Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study 1996. J Infect Dis 2000; 182:168-173.
10. Kotloff KL, Fattom A, Basham L, Hawwari A, Harkonen S, Edelman R. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults. Vaccine 1996; 14:446-450.
11. Jeffrey HE, Moses Lahra M. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998; 101(1):E2.
12. Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 1999; 18:806-810.
13. Poulain P, Betremieux P, Donnio PY, Proudhom JF, Karege G, Giraud JR. Selective intrapartum anti-bioprophylaxis of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Med 1997; 72:137-140.
14. Hafner E, Sterniste W, Rosen A, et al. Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol 1998; 179:677-681.
15. Bignardi GE. Surveillance of neonatal group B streptococcal infection in Sutherland. Commun Dis Public Health 1999; 2:64-65.
16. Beardsall K, Thompson MH, Mulla RJ. Neonatal group B streptococcal infection in South Bedfordshire, 1993-98. Arch Dis Child Fetal Neonat Ed 2000; 82:F205-F207.
17. Moses LM, Heath PT, Wilkinson AR, Jeffery HE, Isaacs D. Early onset group B streptococcal neonatal infection in Oxford, 1985-96. Arch Dis Child Fetal Neonat Ed 1998; 79: F148-F149.
18. Aavitsland P, Hoiby EA, Lystad A. Systemic group B streptococcal disease in neonates and young infants in Norway, 1985-94. Acta Pediatr 1996; 85:104-105.
19. Henning KJ, Hall EL, Dwyer DM, et al. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis 2001; 183:1138-1142.
20. Cooper BW, Morganelli E. Group B streptococcal bacteremia in adults at Hartford Hospital 1991-1996. Conn Med 1998; 62:515-517.
21. Jackson LA, Hildson R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123:415-420.
22. Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, Broome CV. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991; 266:1112-1114.
23. Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 2001; 33:667-672.
24. Blumberg HM, Stephens DS, Modansky M, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996; 173:365-373.
25. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Morb Mortal Wkly Rep CDC Surveill Summ 1992; 41:25-32.
26. Perovic O, Crewe-Brown HH, Khoosal M, Karstaedt AS. Invasive group B streptococcal disease in nonpregnant adults. Eur J Clin Microbiol Infect Dis 1999; 18:362-364.
27. Hibbs JR, Douglas JM Jr, Judson FN, McGill WL, Rietmeijer CA, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis 1997; 25:195-199.
28. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease; clinical features, serotypes and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23:577-584.
29. Nuorti JP, Butler JC, Gelling L, Kool JL, Rehingold AL, Vugia DJ. Epidemiological relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132:182-190.
30. Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med 1995; 123:421-427.
31. Cheng Q, Carlson B, Pillai S, et al. Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect Immun 2001; 69:2302-2308.
32. Larsson C, Stalhammar-Carlemalm M, Lindahl G. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine. Vaccine 1999; 17:454-458.
33. Lagergard T, Thiringer K, Wassén L, Schneerson R, Trollfors B. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Eur J Pediatr 1992; 151:98-102.
34. Adriaanse AH. Prevention of neonatal septicemia due to group B streptococci. Baillieres Clin Obstet Gynecol 1995; 9:545-552.
35. Lin FY, Philips JB 3rd, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 2001; 184: 1022-1028.
36. Centers for Disease Control. Recommendations of the immunisation practices advisory committee: pneumococcal polysaccaride vaccine. MMWR Morb Mortal Wkly Rep 1989; 38:64-76.